Zdrowie i gospodarka · 09/09/2026
FDA Announces Temporary Guidance for Compounding Parenteral Nutrition Drugs for Neonates
The FDA is releasing a new guidance document outlining its priorities for regulating the compounding of certain starter parenteral nutrition drugs for neonates, as a major supplier is set to exit the US market